Loading clinical trials...
Loading clinical trials...
Strategic Intervention on Preserving Motor Function With Application of Monopolar Stimulator During Awake Glioma Resection Surgery
This study aims to compare the motor functions after traditional or a new surgical plan during awake glioma resection surgery.
This study concentrates on patients with type III motor area glioma. In the awake surgery, The investigators compare the new surgical plan, which the investigators use a monopolar stimulator to determine and retain the tumor margin within 5mm from the posterior limb of the inner capsule. For the traditional surgical plan, the investigators use bipolar stimulator according to the current standard surgery plan. After the positive points are identified by stimulator, the positive points are retained in order to preserve the motor function while all the non-positive points of the tumor are resected. This study is designed to determine whether the new surgical plan is more suitable for type III motor area glioma patients.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Start Date
December 1, 2021
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2023
Last Updated
December 20, 2021
60
ESTIMATED participants
Awake craniotomy
PROCEDURE
Lead Sponsor
Beijing Neurosurgical Institute
Collaborators
NCT05099003
NCT05839379
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06860594